Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,713,000 | 3,914,000 | 12,402,000 | 9,773,000 | 6,529,000 |
| Depreciation Amortization | 3,295,000 | 1,366,000 | 5,733,000 | 4,222,000 | 2,673,000 |
| Accounts receivable | N/A | N/A | -1,728,000 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 1,346,000 | N/A | N/A |
| Other Working Capital | -1,438,000 | -1,000,000 | -1,137,000 | 64,000 | -771,000 |
| Other Operating Activity | -2,346,000 | -921,000 | -2,041,000 | -1,826,000 | -1,332,000 |
| Operating Cash Flow | $6,224,000 | $3,359,000 | $14,575,000 | $12,233,000 | $7,099,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -45,000 | -85,000 | 131,000 | 122,000 | 115,000 |
| PPE Investments | -1,298,000 | -539,000 | -2,797,000 | -1,764,000 | -1,078,000 |
| Net Acquisitions | N/A | N/A | -1,230,000 | -60,000 | N/A |
| Purchase Of Investment | -32,000 | -32,000 | -239,000 | -228,000 | -188,000 |
| Sale Of Investment | 3,000 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -3,168,000 | -946,000 | -2,959,000 | -2,748,000 | -1,709,000 |
| Other Investing Activity | -3,332,000 | -1,136,000 | -2,673,000 | -3,432,000 | -2,210,000 |
| Investing Cash Flow | $-4,704,000 | $-1,792,000 | $-6,808,000 | $-5,362,000 | $-3,361,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,315,000 | 2,334,000 | 364,000 | 1,382,000 | 1,734,000 |
| Debt Issued | 1,997,000 | 1,990,000 | 15,000 | 9,000 | 9,000 |
| Debt Repayment | -2,453,000 | -2,000 | -2,029,000 | -20,000 | -16,000 |
| Common Stock Issued | 16,000 | 10,000 | 40,000 | 17,000 | 12,000 |
| Common Stock Repurchased | -658,000 | -612,000 | -521,000 | -508,000 | -489,000 |
| Dividend Paid | -3,288,000 | -3,287,000 | -4,971,000 | -4,968,000 | -3,357,000 |
| Other Financing Activity | -254,000 | -166,000 | -442,000 | -174,000 | -82,000 |
| Financing Cash Flow | $-2,325,000 | $267,000 | $-7,544,000 | $-4,262,000 | $-2,189,000 |
| Exchange Rate Effect | -9,000 | -18,000 | 46,000 | 42,000 | 54,000 |
| Beginning Cash Position | 5,698,000 | 5,698,000 | 5,429,000 | 5,429,000 | 5,429,000 |
| End Cash Position | 4,884,000 | 7,514,000 | 5,698,000 | 8,080,000 | 7,032,000 |
| Net Cash Flow | $-814,000 | $1,816,000 | $269,000 | $2,651,000 | $1,603,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,224,000 | 3,359,000 | 14,575,000 | 12,233,000 | 7,099,000 |
| Capital Expenditure | -1,310,000 | -547,000 | -2,810,000 | -1,774,000 | -1,088,000 |
| Free Cash Flow | 4,914,000 | 2,812,000 | 11,765,000 | 10,459,000 | 6,011,000 |